Silvant Capital Management’s Insmed INSM Stock Holding History

Silvant Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.25M	Buy	19,905 +321	+2%	+$49.4K	0.11%	105
2025 Q4	$3.41M	Buy	+19,584	New	+$3.57M	0.12%	104
2022 Q4	–	Sell	-7,341	Closed	-$158K	–	321
2022 Q3	$158K	Hold	7,341	–	–	0.01%	215
2022 Q2	$145K	Hold	7,341	–	–	0.04%	176
2022 Q1	$173K	Hold	7,341	–	–	0.03%	178
2021 Q4	$200K	Sell	7,341 -472	-6%	-$13.5K	0.03%	176
2021 Q3	$215K	Hold	7,813	–	–	0.04%	178
2021 Q2	$222K	Hold	7,813	–	–	0.04%	177
2021 Q1	$266K	Hold	7,813	–	–	0.05%	168
2020 Q4	$260K	Hold	7,813	–	–	0.04%	169
2020 Q3	$251K	Hold	7,813	–	–	0.05%	159
2020 Q2	$215K	Buy	7,813 +2,543	+48%	+$60.3K	0.04%	164
2020 Q1	$84K	Hold	5,270	–	–	0.02%	210
2019 Q4	$126K	Hold	5,270	–	–	0.02%	212
2019 Q3	$93K	Hold	5,270	–	–	0.02%	227
2019 Q2	$135K	Buy	+5,270	New	+$147K	0.02%	211

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Silvant Capital Management's INSM Position: Q1 2026 in Review

Silvant Capital Management increased its Insmed (INSM) stake by 1.6% in Q1 2026, buying an estimated $49.4K and bringing the position to 19,905 shares worth $3.25M. The position accounts for 0.11% of the portfolio, ranked #105.

Silvant Capital Management first reported a position in INSM in Q2 2019 and has held it in 16 quarters since. The position peaked at $3.41M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Silvant Capital Management held 19,905 shares of Insmed worth $3.25M as of Q1 2026.
Silvant Capital Management bought 321 Insmed shares in Q1 2026, an estimated $49.4K.
Insmed made up 0.11% of Silvant Capital Management's portfolio in Q1 2026, its #105 holding.
Silvant Capital Management first reported a position in Insmed in Q2 2019 and has held it in 16 quarters since.
Silvant Capital Management's Insmed position peaked at $3.41M in Q4 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.